CRP and COVID-19: In line with the aggravating effects of human pCRP*/mCRP in animal models, recent clinical studies revealed a correlation between CRP concentration and cardiac infarct size (Ries et al, 2021), and clinical deterioration and harmful inflammatory responses in COVID‐19.